Atlas Trials

Nicotinamide-based Supportive Therapy in Lymphopenia for Patients With COVID-19

Clinical trial NCT04910230 · COMPLETED

Trial details

NCT number
NCT04910230
Sponsor
Qiang Hu
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Covid19Lymphopenia
Start date
2020-03-01
Primary completion
2020-04-02
Enrollment
24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.